Vertaling van "ast methods have been reported " (Nederlands → Frans) :

Many of the early generation automated AST methods have been reported to be unreliable as a means of detecting MRSA.
Bon nombre des méthodes automatisées AST de la première génération ont été renseignées comme non fiables pour MRSA.

If this amount had been used as an impairment charge, the Group’s reported net income in 2008 of USD 8.2 billion would have been reduced by approximately USD 3.5 billion to USD 4.7 billion.
Si ce montant avait été porté en tant que charge pour perte de valeur, le résultat net d’USD 8,2 milliards du Groupe publié pour 2008 aurait été réduit d’environ USD 3,5 milliards à USD 4,7 milliards.

Other decolonisation regimens have been described with limited success but can be an alternative: among others, topical decontamination with povidone-iodine 55 , tea tree oil 56 or nitrofurazone (Furacine®) have been reported successful 57,58 .
D'autres traitements de décolonisation ont été décrits avec un succès limité mais ils peuvent constituer une alternative: des décontaminations topiques avec de la povidone-iodine 54 , de l’huile d’arbre à thé 55 ou du nitrofurazone (Furacine®) 56,57 se sont avérées efficaces.

In preparation, a test phase has been organised and the responsible persons of tissue and cell banks have been asked to start making reports to the FAMHP on a voluntary basis in the course of 2008.
In preparation, a test phase has been organised and the responsible persons of tissue and cell banks have been asked to start making reports to the FAMHP on a voluntary basis in the course of 2008.

haemovigilance data and monitoring their implementation ●● The first annual report of the Haemovigilance Centre was published in 2007 Since November 2005, hospitals and blood establishments have been required to report to the Belgian Centre for Haemovigilance of the FAMHP serious reactions during the collection or administration of blood components and serious events relating to the quality or safety of blood components.
haemovigilance data and monitoring their implementation ●● The first annual report of the Haemovigilance Centre was published in 2007 Since November 2005, hospitals and blood establishments have been required to report to the Belgian Centre for Haemovigilance of the FAMHP serious reactions during the collection or administration of blood components and serious events relating to the quality or safety of blood components.

This release contains forward-looking information about an agreement by Pfizer to acquire FoldRx, and about FoldRx’s product candidate tafamidis, its other clinical and preclinical development programs and its technology platform, including their potential benefits, that involves substantial risks and uncertainties. Such risks and uncertainties include, among other things, the satisfaction of conditions to closing the agreement; the uncertainties inherent in research and development; whether and when a new drug application for tafamidis will be filed with the FDA; decisions by regulatory authorities regarding whether and when to approve any drug applications that have been or may be filed for tafamidis and that may be filed for any other product candidates that may be generated by FoldRx’s technology platform as well as their decisions regarding labeling and other matters that could affect the availability or commercial potential of tafamidis and such other product candidates; and competitive developments. A further description of risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2009 and in its reports on Form 10-Q and Form 8-K.
Such risks and uncertainties include, among other things, the satisfaction of conditions to closing the agreement; the uncertainties inherent in research and development; whether and when a new drug application for tafamidis will be filed with the FDA; decisions by regulatory authorities regarding whether and when to approve any drug applications that have been or may be filed for tafamidis and that may be filed for any other product candidates that may be generated by FoldRx’s technology platform as well as their decisions regarding labeling and other matters that could affect the availability or commercial potential of tafamidis and such other product candidates; and competitive developments.

As mentioned above, quite a number of considerations and advisory reports have been issued about “Red Bull”, which was, historically, the first of these beverages and is still the most famous.
Comme indiqué ci-avant, bon nombre de considérations et avis rendus ont porté sur « Red Bull », historiquement la première mais aussi encore actuellement la plus connue de ces boissons.

The recommendations made in this report are based on the available epidemiological data, the main observations that have been made with regard to the problem and an inventory of the actions already put in place in Belgium.
Les recommandations émises découlent des données épidémiologiques disponibles, des principaux constats établis par rapport au problème et d’un inventaire d’actions déjà mises en place en Belgique.

The initial results of the “Active pharmacovigilance” project have been very encouraging given that the number of reports received by the FAMHP has more or less doubled between 2007 and 2008.
The initial results of the “Active pharmacovigilance” project have been very encouraging given that the number of reports received by the FAMHP has more or less doubled between 2007 and 2008.